Cognizant Technology SolutionsNASDAQ: CTSH

Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.

Look into how Cognizant's (CTSH) income from global markets is evolving and how this affects Wall Street's forecasts and the future of the stock.

Investors looking at Business - Software Services stocks probably know about Cognizant (CTSH) and Wipro Limited (WIT). However, which of these two stocks is more appealing for value investors?

CTSH's results for the third quarter of 2024 show improvement due to a growing number of clients and strong AI-based solutions.

Cognizant Technology Solutions exceeded Wall Street's profit expectations for the third quarter on Wednesday, benefiting from a rise in demand as more companies seek the services of the IT provider.

Cognizant (CTSH) reported quarterly earnings of $1.25 per share, which is higher than the Zacks Consensus Estimate of $1.14 per share. This is an increase compared to earnings of $1.16 per share from the same period last year.

Cognizant introduced Synapse around a year ago as a worldwide initiative to help people gain the technology skills necessary for future jobs. This program aims to prepare individuals for the evolving workforce. It is based in Teaneck, New Jersey.

Cognizant and AWS have partnered to introduce generative AI solutions aimed at improving manufacturing operations for large companies in various sectors, including industrial, automotive, life sciences, and consumer goods. On October 29, 2024, Cognizant announced this strategic collaboration agreement, which will focus on providing advanced technology and cloud services. The goal is to enhance smart manufacturing capabilities for businesses worldwide.

Cognizant has announced a new partnership with Alnylam Pharmaceuticals, a top biopharmaceutical company known for its work in RNA interference (RNAi) therapies. The collaboration will use Cognizant's advanced managed services tools to improve automation and lessen operational workloads for Alnylam. This agreement was revealed on October 29, 2024, in Teaneck, New Jersey.